Octagon Capital Advisors

Octagon Capital Advisors as of March 31, 2023

Portfolio Holdings for Octagon Capital Advisors

Octagon Capital Advisors holds 35 positions in its portfolio as reported in the March 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Apellis Pharmaceuticals (APLS) 30.8 $214M 3.3M 65.96
Chinook Therapeutics 8.5 $59M 2.6M 23.15
Verona Pharma Sponsored Ads (VRNA) 7.1 $50M 2.5M 20.08
Cymabay Therapeutics 5.7 $40M 4.6M 8.72
Arcus Biosciences Incorporated (RCUS) 5.7 $40M 2.2M 18.24
Miragen Therapeutics (VRDN) 4.3 $30M 1.2M 25.44
Roivant Sciences SHS (ROIV) 4.1 $29M 3.9M 7.38
Mirati Therapeutics 4.0 $28M 750k 37.18
Celldex Therapeutics Com New (CLDX) 3.9 $27M 760k 35.98
Bridgebio Pharma (BBIO) 3.4 $24M 1.4M 16.58
Tandem Diabetes Care Com New (TNDM) 2.8 $19M 475k 40.61
Aerovate Therapeutics (AVTE) 1.8 $13M 622k 20.17
Jasper Therapeutics 1.7 $12M 6.4M 1.81
Travere Therapeutics (TVTX) 1.6 $11M 495k 22.49
Alpine Immune Sciences (ALPN) 1.3 $9.3M 1.2M 7.72
4d Molecular Therapeutics In (FDMT) 1.2 $8.6M 500k 17.19
Iteos Therapeutics (ITOS) 1.2 $8.1M 596k 13.61
Dyne Therapeutics (DYN) 1.1 $8.0M 693k 11.52
Xilio Therapeutics (XLO) 1.1 $7.7M 2.4M 3.17
Viking Therapeutics (VKTX) 0.9 $6.2M 375k 16.65
Vera Therapeutics Cl A (VERA) 0.9 $6.2M 795k 7.76
89bio (ETNB) 0.9 $6.1M 400k 15.23
Avidity Biosciences Ord (RNA) 0.8 $5.9M 382k 15.35
Intra Cellular Therapies (ITCI) 0.7 $5.1M 95k 54.15
Geron Corporation (GERN) 0.7 $4.9M 2.3M 2.17
Aclaris Therapeutics (ACRS) 0.7 $4.7M 577k 8.09
Annexon (ANNX) 0.7 $4.6M 1.2M 3.85
Glycomimetics (GLYC) 0.5 $3.8M 3.0M 1.26
Reneo Pharmaceuticals (RPHM) 0.4 $2.5M 420k 5.98
Gossamer Bio (GOSS) 0.4 $2.5M 2.0M 1.26
Structure Therapeutics Sponsored Ads (GPCR) 0.3 $2.2M 94k 23.79
Stoke Therapeutics (STOK) 0.2 $1.5M 186k 8.33
Centessa Pharmaceuticals Sponsored Ads (CNTA) 0.2 $1.5M 396k 3.85
Vectivbio Hldg Ord Shs 0.0 $300k 35k 8.51
Pieris Pharmaceuticals (PIRS) 0.0 $294k 302k 0.98